Cargando…

Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin

Background: The contemporary guidelines have recommended multiple antimicrobial therapies along with oral macrolides for the treatment of Mycobacterium abscessus complex lung disease (MABC-LD). However, there is little evidence supporting the parenteral tigecycline-containing regimens against MABC-L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jeng-How, Wang, Ping-Huai, Pan, Sheng-Wei, Wei, Yu-Feng, Chen, Chung-Yu, Lee, Ho-Sheng, Shu, Chin-Chung, Wu, Ting-Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137771/ https://www.ncbi.nlm.nih.gov/pubmed/35625215 http://dx.doi.org/10.3390/antibiotics11050571

Ejemplares similares

Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
por: Portell-Buj, Elena, et al.
Publicado: (2021)

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China
por: Zhang, Zhijian, et al.
Publicado: (2022)

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019)

Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species
por: Jong, Bor-En, et al.
Publicado: (2022)

Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis
por: Li, Haoran, et al.
Publicado: (2022)

Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
por: Aziz, Dinah B., et al.
Publicado: (2018)

Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo
por: Pearce, Camron, et al.
Publicado: (2020)

Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
por: Palucci, Ivana, et al.
Publicado: (2023)

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
por: Li, Anqi, et al.
Publicado: (2023)

Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience
por: Chiron, Raphael, et al.
Publicado: (2022)

Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates
por: Kim, Su-Young, et al.
Publicado: (2021)

Mycobacterium abscessus Complex Infections in Humans
por: Lee, Meng-Rui, et al.
Publicado: (2015)

Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus
por: Ng, Hien Fuh, et al.
Publicado: (2022)

Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
por: Wallace, Richard J., et al.
Publicado: (2014)

Mixed Infection of Mycobacterium abscessus subsp. abscessus and Mycobacterium tuberculosis in the Lung
por: Sohn, Sungmin, et al.
Publicado: (2017)

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
por: Henriette Zweijpfenning, Sanne Maria, et al.
Publicado: (2022)

Mycobacterium abscessus: It’s Complex
por: Abdelaal, Hazem F. M., et al.
Publicado: (2022)

Prevalence of Latent Tuberculous Infection in Patients With Nontuberculous Mycobacterial Lung Disease and Colonization: A Prospective Study in an Intermediate Tuberculosis Burden Country
por: Lee, Ho-Sheng, et al.
Publicado: (2022)

Antimicrobial Effect of Oxazolidinones and Its Synergistic Effect with Bedaquiline Against Mycobacterium abscessus Complex
por: Gao, Tianhui, et al.
Publicado: (2023)

Clinical aspects of the Mycobacterium abscessus complex
por: Joob, Beuy, et al.
Publicado: (2018)

Mycobacterium abscessus Complex Osteomyelitis of the Wrist
por: Alter, Noah, et al.
Publicado: (2022)

Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the whiB7 Gene
por: Pryjma, Mark, et al.
Publicado: (2017)

Successful management of Mycobacterium abscessus complex lung disease in an otherwise healthy infant
por: Liu, Hui, et al.
Publicado: (2019)

Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination
por: Pryjma, Mark, et al.
Publicado: (2018)

Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae
por: Ni, Wentao, et al.
Publicado: (2016)

Importance of Reciprocal Balance of T Cell Immunity in Mycobacterium abscessus Complex Lung Disease
por: Kim, Su-Young, et al.
Publicado: (2014)

Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

Amikacin liposome and Mycobacterium avium complex: A systematic review
por: Zangiabadian, Moein, et al.
Publicado: (2022)

Spontaneous sputum conversion and reversion in Mycobacterium abscessus complex lung disease
por: Jo, Kyung-Wook, et al.
Publicado: (2020)

Mycobacterium abscessus subsp abscessus lung disease: ‘trouble ahead, trouble behind…’
por: Griffith, David E.
Publicado: (2014)

Rifabutin Is Active against Mycobacterium abscessus Complex
por: Aziz, Dinah Binte, et al.
Publicado: (2017)

Canaliculitis por Mycobacterium abscessus subsp. abscessus
por: Tello, María Nieves Carmona, et al.
Publicado: (2021)

The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease
por: Wang, Ping-Huai, et al.
Publicado: (2022)

Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

Complete Genome Sequence of a Type Strain of Mycobacterium abscessus subsp. bolletii, a Member of the Mycobacterium abscessus Complex
por: Yoshida, Mitsunori, et al.
Publicado: (2018)

Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series
por: Namkoong, Ho, et al.
Publicado: (2016)

Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex
por: Rubio, Marc, et al.
Publicado: (2015)

Effect of Coptis chinensis on Biofilm Formation and Antibiotic Susceptibility in Mycobacterium abscessus
por: Tseng, Cheng-Yin, et al.
Publicado: (2020)

Rapid and Accurate Discrimination of Mycobacterium abscessus Subspecies Based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Spectrum and Machine Learning Algorithms
por: Wang, Hsin-Yao, et al.
Publicado: (2022)

1418. Pharmacokinetics (PK) and Toxicity of Intravenous Amikacin (AMK) Dosed Three Times a Week (TIW) for Treatment of Disseminated Mycobacterium abscessus Infection in Children
por: Tran, M Tuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ovgeojdkrt1mbe08q2u10hra0